Ocular Therapeutix’s experimental eye drug showed superiority to Regeneron’s Eylea in a key late-stage trial, but its modest advantage and higher rates of certain side… Reuters Health Information
Category: News
New Rx Option for Neuromyelitis Optica Spectrum Disorder?
Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder. Medscape Medical News
Optometry Practices Elevate Patient Experience with RevolutionEHR’s Integrated, Modernized Patient Portal
SAN DIEGO–(BUSINESS WIRE)– #ONCCompliant–RevolutionEHR launches a modern, compliance-first patient portal that streamlines scheduling, billing, messaging, and records for optometry practices.
Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be releas…
Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that the first patient has been dosed in t…
Metabolic Syndrome Tied to Glaucoma Risk
Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening. Medscape Medical News
Two Biologics Show Comparable Benefit in Uveitis
Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis. Medscape Medical News
Warby Parker Appoints Adrian Mitchell as Chief Financial Officer
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment stren…
Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis
In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease. Medscape Medical News
Worsening Heart-Kidney-Metabolic Health May Threaten Vision
People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration. Medscape Medical News
iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company advancing innovative pharmacologic therapies for refractive eye diseases, today announced key executive promotions designed to strengthen …
PRAME TCR Therapy Delivers Breakthrough in Uveal Melanoma
Dr Teresa Amaral reviews ESMO 2025 data showing unprecedented response rates with PRAME-directed TCR therapy in metastatic uveal melanoma. Medscape Oncology
Mary Tyler Moore Initiative Combats Diabetic Retinal Disease
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate treatment. Medscape Medical News
FDA Approves First Dual-Agent Eye Drop for Presbyopia
The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults. Medscape Medical News
Novel Geographic Atrophy Measure Aligns With Vision Clarity
A novel measure of geographic atrophy shows a stronger correlation with vision loss than the area of the lesion and could aid in tracking functional decline. Medscape Medical News
Infographic: Physical Security at Work ‒ Do You Feel Safe?
Physicians surveyed by Medscape told how protected they feel from assaults and thefts at the medical offices or hospitals where they work. Medscape
Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs
LONDON–(BUSINESS WIRE)– #aiml–Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ve…
Weight-Loss Drug Beats Lifestyle in Saving Eyes in Diabetes
Diabetes patients on tirzepatide have lower risks for new or worsening diabetic retinopathy, eye complications, and the need for eye treatments than those relying on lifestyle interventions alone. Medscape Medical News
Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced it has secured $235 million through the su…
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that the U.S. Food and Drug Administration (F…